PharmswellBio Co Ltd operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares PharmswellBio Co Ltd with three other
companies in this sector in South Korea:
Nibec
(2017
sales of 6.30 billion Korean Won [US$5.60 million]
),
Bioleaders Corp
(7.61 billion Korean Won [US$6.76 million]
), and
Enzychem Lifesciences Corp
(26.13 billion Korean Won [US$23.21 million]
of which 95%
was Medicines).
Sales Analysis.
During the year ended December of 2017, sales at
PharmswellBio Co Ltd were 19.59 billion Korean Won (US$17.40 million).
This
is
an
increase of 24.6%
versus 2016, when the company's sales were 15.72 billion Korean Won.
Sales of Other saw an increase
that was more than double the company's growth rate: sales were up
2,559.1% in 2017, from
242.09 million Korean Won to 6.44 billion Korean Won.
Not all segments of PharmswellBio Co Ltd experienced an increase in sales in 2017:
sales of Synthesis fell 15.0% to 13.16 billion Korean Won.